--- title: "With a net profit of nearly 1.5 billion in a year, a year-on-year surge of 68%, this Beijing manufacturer is incredibly good at attracting capital" type: "News" locale: "en" url: "https://longbridge.com/en/news/225815339.md" description: "Ultrapower expects its net profit attributable to shareholders in 2024 to reach between 1.38 billion and 1.49 billion yuan, a year-on-year increase of 55.7% to 68.1%. This is mainly due to the stable revenue growth of its subsidiary Kemu Games' products such as \"Age of Origins\" and \"War and Order,\" as well as the implementation of precise marketing strategies. Since being acquired in 2013, Kemu Games has achieved six consecutive years of revenue and profit growth, with operating revenue approaching 20 billion yuan and net profit nearing 4 billion yuan in 2023" datetime: "2025-01-22T09:51:35.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/225815339.md) - [en](https://longbridge.com/en/news/225815339.md) - [zh-HK](https://longbridge.com/zh-HK/news/225815339.md) generator: "portal-rs" --- # With a net profit of nearly 1.5 billion in a year, a year-on-year surge of 68%, this Beijing manufacturer is incredibly good at attracting capital Author: Evil Cat Image source | pexels On January 21, Ultrapower released its full-year performance forecast for 2024. According to the financial report, the company expects a net profit attributable to the parent company of approximately 1.38 billion to 1.49 billion yuan in 2024, an increase of 55.7% to 68.1% compared to the same period last year (887 million yuan); the net profit excluding non-recurring items is expected to be around 1 billion to 1.21 billion yuan, an increase of 32.4% to 45.7% compared to the same period last year (829 million yuan). The main reason is the stable revenue growth of its subsidiary Kemu Games' major products such as "Age of Origins" and "War and Order," while also reducing marketing expenditures through precise marketing strategies, leading to profit growth in the gaming business. It is worth mentioning that since Kemu Games was acquired in 2013, they have not only withstood the pressure during the earn-out agreement period but have also achieved dual growth in annual revenue and profit for six consecutive years. As of 2023, Kemu Games achieved operating revenue close to 20 billion yuan and a net profit of nearly 4 billion yuan. Looking specifically at the product level, "Age of Origins" has maintained a leading position in the overseas SLG market since its launch in 2018, frequently appearing in the top 10 of SensorTower's monthly revenue rankings for overseas games. Taking the iOS bestseller list in the United States as an example, the game has consistently ranked within the Top 40 over the past year, even reaching as high as Top 7 at one point, demonstrating its enduring vitality. Another key product, "War and Order," is also an SLG game that has been online for 8 years and still holds significant market influence. In recent years, Kemu has made a series of updates and iterations to the game, such as art upgrades and the addition of various monetization sub-play styles, resulting in a resurgence and increase in the game's revenue In fact, the impressive performance of the two products has already been reflected in last year's semi-annual report. According to official sources, together they accounted for 96.83% of the total revenue from the gaming business, with the revenue from "Age of Origins" alone reaching 1.789 billion yuan in the first half of 2024. In addition to the continued success of existing products, several new products are also in preparation, ready to launch. It is reported that the two new games from Kemu, "Stellar Sanctuary" and "Next Agers," have already begun commercial testing overseas and will be launched domestically at an appropriate time. Among them, "Stellar Sanctuary" combines American comic style with a sci-fi worldview, incorporating many simulation management elements into its gameplay, aiming to create a casual SLG experience to attract external users. Currently, the Chinese name for the game has been confirmed as "Legend of the Wasteland: Breath of the Shepherd," and it has obtained a domestic game license. "Next Agers," on the other hand, focuses on a multi-civilization theme with an "SLG+" approach, integrating diverse sub-gameplay suitable for user acquisition in the early stages, such as vampire-like and roguelike tower defense. In the SLG city-building aspect, it revolves around the theme of civilization progress, mainly showcasing style changes across different eras, providing players with a stronger sense of immersion, while also being suitable for casual players. However, both games are currently only in the commercial testing phase, and whether they can become the next hit SLG products for Ultrapower remains to be seen through longer-term market validation. Regardless, under the current cold environment, their performance last year is undoubtedly quite remarkable, and Ultrapower is one of the few companies in the A-share market that has maintained profit growth in recent years. Once the subsequent official financial reports are disclosed, the outside world may have a more detailed and clear understanding of this company, and we will also conduct further follow-up reports on this matter ### Related Stocks - [300002.CN](https://longbridge.com/en/quote/300002.CN.md) ## Related News & Research - [NRED Identifies Stronger Untested IP Targets Beyond 1.67% Copper Trench Mineralization at Wilmac | NREDF Stock News](https://longbridge.com/en/news/296612079.md) - [Jim Ratcliffe rescues vital British plastics factory from collapse](https://longbridge.com/en/news/296637993.md) - [08:31 ETTiger Group Offers Lab Equipment, Plastics Inventory and More from Grow Materials, LLC](https://longbridge.com/en/news/296491453.md) - [Lithium Chile sale to China Union faces Canada national security review notice under Investment Canada Act](https://longbridge.com/en/news/296103579.md) - [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**